Literature DB >> 15093984

Right ventricular myocardial dysfunction in adult patients late after repair of tetralogy of fallot.

A D'Andrea1, P Caso, B Sarubbi, M G Russo, L Ascione, M Scherillo, M Cobrufo, Raffaele Calabrò.   

Abstract

AIM OF THE STUDY: To detect in adult patients late after repair of Tetralogy of Fallot (TOF) possible correlation between myocardial parameters assessed at rest by Tissue Doppler (TD) and cardiac performance during physical effort.
METHODS: Doppler echo, treadmill test and pulsed TD of both mitral and tricuspid annulus were performed in 25 healthy subjects and in 40 adult patients who had undergone surgery for TOF at a mean age of 1.4+/-0.5 years. Exclusion criteria were echocardiographic evidence of residual pulmonary, either stenosis or regurgitation. By use of TD, the following parameters were assessed: systolic peak velocities (Sm), pre-contraction time, contraction time, early (E(m)) and late (A(m)) diastolic velocities, E(m)/A(m) ratio, relaxation time. By treadmill test, we measured: maximal heart rate (HR), systolic blood pressure (SBP), rate-pressure product, maximal workload, time duration of the exercise.
RESULTS: the two groups were comparable for left ventricular measurements and for all transmitral and transtricuspid Doppler indexes, while tricuspid ring diameter was increased in TOF. TD analysis showed in TOF lower S(m), E(m) and E(m)/A(m) ratio and prolonged PCT(m) and Rt(m) at tricuspid annulus level, despite comparable TD mitral annulus indexes. By treadmill test, TOF showed reduced time of exercise, number of METS reached and rate-pressure product. Multiple linear regression models evidenced in TOF independent positive association between tricuspid Em velocity and time of exercise (p<0.0001), achieved METS at peak effort (p<0.001) and rate-pressure product (p<0.001). An E(m) peak velocity of tricuspid annulus lower than 0.13 m/s showed 90% sensitivity and 93% specificity in identifying TOF patients unable to perform maximal exercise test.
CONCLUSIONS: despite normal Doppler parameters, adult patients late after correction of TOF showed impaired right ventricular myocardial function. In these patients pulsed TD may be taken into account as a valuable supporting tool to predict the effort response and possibly to assess long-term follow-up of cardiac functional reserve.

Entities:  

Mesh:

Year:  2004        PMID: 15093984     DOI: 10.1016/j.ijcard.2003.04.033

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

1.  Clinical value of Tei index in pediatric patients with repaired tetralogy of Fallot.

Authors:  Bing Song; Quan Qi; Ruisheng Liu; Wang Xing; Hanbo Tang; Yuanmin Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Pediatric cardiology for the primary care pediatrician.

Authors:  M Regina Lantin-Hermoso
Journal:  Indian J Pediatr       Date:  2005-06       Impact factor: 1.967

Review 3.  Ventricular performance after surgery for a congenital heart defect as assessed using advanced echocardiography: from doppler flow to 3D echocardiography and speckle-tracking strain imaging.

Authors:  Liselotte M Klitsie; Arno A W Roest; Nico A Blom; Arend D J ten Harkel
Journal:  Pediatr Cardiol       Date:  2014-01       Impact factor: 1.655

4.  Tissue Doppler imaging detects impaired biventricular performance shortly after congenital heart defect surgery.

Authors:  Liselotte M Klitsie; Mark G Hazekamp; Arno A W Roest; Annelies E Van der Hulst; Birthe J Gesink-van der Veer; Irene M Kuipers; Nico A Blom; Arend D J Ten Harkel
Journal:  Pediatr Cardiol       Date:  2012-09-22       Impact factor: 1.655

5.  Ratio of early diastolic tricuspid inflow to tricuspid lateral annulus velocity reflects pulmonary regurgitation severity but not right ventricular diastolic function in children with repaired Tetralogy of Fallot.

Authors:  Yasunobu Hayabuchi; Miho Sakata; Tatsuya Ohnishi; Miki Inoue; Shoji Kagami
Journal:  Pediatr Cardiol       Date:  2012-12-18       Impact factor: 1.655

6.  Right ventricular regional wall curvedness and area strain in patients with repaired tetralogy of Fallot.

Authors:  Liang Zhong; Like Gobeawan; Yi Su; Ju-Le Tan; Dhanjoo Ghista; Terrance Chua; Ru-San Tan; Ghassan Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-30       Impact factor: 4.733

7.  Delayed onset of tricuspid valve flow in repaired tetralogy of Fallot: an additional mechanism of diastolic dysfunction and interventricular dyssynchrony.

Authors:  Ai-Min Sun; Fahad AlHabshan; Michael Cheung; Gabriele Bronzetti; Andrew N Redington; Lee N Benson; Christopher Macgowan; Shi-Joon Yoo
Journal:  J Cardiovasc Magn Reson       Date:  2011-08-24       Impact factor: 5.364

Review 8.  Role of echocardiography in the assessment and management of adult congenital heart disease in pregnancy.

Authors:  Antonio Vitarelli; Lidia Capotosto
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-17       Impact factor: 2.357

9.  Control of cytokinesis by β-adrenergic receptors indicates an approach for regulating cardiomyocyte endowment.

Authors:  Honghai Liu; Cheng-Hai Zhang; Niyatie Ammanamanchi; Sangita Suresh; Christopher Lewarchik; Krithika Rao; Gerrida M Uys; Lu Han; Maryline Abrial; Dean Yimlamai; Balakrishnan Ganapathy; Christelle Guillermier; Nathalie Chen; Mugdha Khaladkar; Jennifer Spaethling; James H Eberwine; Junhyong Kim; Stuart Walsh; Sangita Choudhury; Kathryn Little; Kimberly Francis; Mahesh Sharma; Melita Viegas; Abha Bais; Dennis Kostka; Jun Ding; Ziv Bar-Joseph; Yijen Wu; Vijay Yechoor; Mousumi Moulik; Jennifer Johnson; Jacqueline Weinberg; Miguel Reyes-Múgica; Matthew L Steinhauser; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2019-10-09       Impact factor: 17.956

10.  Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot.

Authors:  Rachel M Wald; Idith Haber; Ron Wald; Anne Marie Valente; Andrew J Powell; Tal Geva
Journal:  Circulation       Date:  2009-03-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.